Bracco Imaging Announces Publication of Data Reinforcing Eff

Bracco Imaging has issued a statement on new results published in the journal Radiology which found that gadopiclenol (VUEWAY), which has half the dose (or the amount) of gadolinium found in other available gadolinium-based contrast agents, provides similar lesion visualization and contrast enhancement compared with gadobuterol (Gadavist).

Related Keywords

United States , South Korea , Hungary , Texas , Poland , Szolnok , Já Nagykun Szolnok , Chicago , Illinois , Germany , University Hospital , Seoul , Soult Ukpyolsi , San Antonio , Republic Of Korea , Christiane Kuhl , Fulvio Renoldi Bracco , Wojciech Piskorski , Hetenyi Geza Korhaz , Tomasz Miszalski , Alberto Spinazzi , Min Lee , Pamelam Otto , Bracco Diagnostics Inc , Drug Administration , Ge Healthcare , Seoul National University Hospital , Department Of Medical Oncology , Bayer Healthcare Pharmaceuticals Inc , Seoul National University College Of Medicine , Department Of Radiology , Liebel Flarsheim Company , American College Of Radiology , Aachen University Hospital , Department Of Clinical Radiology , Department Of Oncology , Bracco Imaging , Body Magnetic , Investigative Radiology , Pharmacy Bulk Package , United States Food , Priority Review , Interventional Radiology , Medical Oncology , Rydgier Memorial Hospital , Clinical Radiology , Imaging Diagnostics , Military Hospital , Jeong Min Lee , Seoul National University College , Texas Health Science Center , Bracco Chief Medical , American College , Bracco Diagnostics , Prescribing Information , Nephrogenic Systemic , Half Dose Gadopiclenol , Full Dose Gadobutrol , Contrast Enhanced Body , Full Prescribing Information , Patient Medication , Monroe Twp , Pharmacokinetic Profiles , New Macrocyclic Gadolinium Chelate , Invest Radiol , Bayer Healthcare Pharmaceuticals , Full Prescribing , Central Nervous ,